India CDMO Market: Growth Opportunities and Considerations
Understanding the Indian pharmaceutical manufacturing landscape for global sourcing.
1 min read1020 viewsPublished May 15, 2025
India CDMO Market: Growth Opportunities and Considerations
Market Position
India is a major global pharmaceutical manufacturing hub, particularly for generic drugs and APIs.
Key Strengths
Cost Advantage
- Competitive pricing
- Lower operational costs
- Skilled workforce
Regulatory Status
- FDA-approved facilities
- WHO prequalification
- EU GMP certifications
Capabilities
- API manufacturing
- Formulation development
- Packaging services
Considerations
Quality Management
- Variable quality standards
- Need for careful due diligence
- Importance of site audits
Regulatory Challenges
- Import alert history
- Data integrity concerns
- Inspection frequency
Selection Criteria
- Regulatory track record
- Quality system maturity
- Capacity and capabilities
- Financial stability
Future Outlook
- Continued API dominance
- Growing biologics capacity
- Quality improvements underway
Was this article helpful?
Sign in to provide feedback